Iradimed (IRMD) EBT Growth (3y) (2016 - 2026)
Iradimed (IRMD) EBT Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | -2.34% |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 20.27% |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 35.51% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 23.63% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 25.85% |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 6.73% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 89.20% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 17.92% |
| 10 | Iradimed | 1.12 Bn | 1.06 Bn | 15.16 Mn | 9.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.14% |
| Mar 31, 2026 | 21.33% |
| Dec 31, 2025 | 18.32% |
| Sep 30, 2025 | 19.87% |
| Jun 30, 2025 | 20.58% |
| Mar 31, 2025 | 24.78% |
| Dec 31, 2024 | 26.78% |
| Sep 30, 2024 | 27.54% |
| Jun 30, 2024 | 50.00% |
| Mar 31, 2024 | 43.58% |
| Dec 31, 2023 | 104.48% |
| Sep 30, 2023 | 100.58% |
| Jun 30, 2023 | 56.32% |
| Mar 31, 2023 | 73.30% |
| Dec 31, 2022 | 25.95% |
| Sep 30, 2022 | 17.25% |
| Jun 30, 2022 | 19.43% |
| Mar 31, 2022 | 23.96% |
| Dec 31, 2021 | 18.40% |
| Sep 30, 2021 | 27.56% |